Recent studies show COVID-19 convalescents had a higher level of CETP than the healthy cohort and lipoprotein lipase was impaired by the elevated IL-6 and TNF-α in addition to increased hepatic lipase in the LC cohort(Almulla et al., 2025; Pushalkar et al., 2024). This evidence concerns the gene LPL and COVID-19.